Private Capital Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Private Capital Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-74	Closed	-$5K	–	2114
2020 Q3	$5K	Hold	74	–	–	﹤0.01%	1511
2020 Q2	$5K	Hold	74	–	–	﹤0.01%	1528
2020 Q1	$4K	Hold	74	–	–	﹤0.01%	1552
2019 Q4	$4K	Hold	74	–	–	﹤0.01%	1562
2019 Q3	$4K	Sell	74 -239	-76%	-$13.7K	﹤0.01%	1736
2019 Q2	$21K	Buy	313 +239	+323%	+$14.7K	﹤0.01%	1062
2019 Q1	$5K	Sell	74 -89	-55%	-$5.85K	﹤0.01%	1678
2018 Q4	$10K	Sell	163 -150	-48%	-$10.1K	﹤0.01%	1397
2018 Q3	$23K	Hold	313	–	–	﹤0.01%	1089
2018 Q2	$21K	Sell	313 -514	-62%	-$33.1K	﹤0.01%	1095
2018 Q1	$52K	Buy	827 +289	+54%	+$19K	0.01%	662
2017 Q4	$53K	Buy	+538	New	+$34.5K	0.01%	667

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

AWMS

Advocacy Wealth Management Services Atlanta, Georgia $2.75B AUM 19.24% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Capital Group's PJP Position: Q4 2020 in Review

Private Capital Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2020, closing a stake of 74 shares — an estimated $5K sold.

Private Capital Group first reported a position in PJP in Q4 2017 and held it in 12 quarters. The position peaked at $53K in Q4 2017. 87 funds tracked by Wall St. Rank hold PJP as of Q4 2020.

Private Capital Group reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2020 after selling out during the quarter.
Private Capital Group sold 74 Invesco Pharmaceuticals ETF shares in Q4 2020, an estimated $5K.
Private Capital Group first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and held it in 12 quarters.
Private Capital Group's Invesco Pharmaceuticals ETF position peaked at $53K in Q4 2017.
87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2020.

Based on Private Capital Group's 13F filing for Q4 2020, filed 26 Jan 2021.